title: Erythropoietin for ribavirin-induced anemia in hepatitis C: more answers but many more questions.
authors.forename: Anouk
authors.initials: A
authors.lastname: Dev
authors.forename: Keyur
authors.initials: K
authors.lastname: Patel
authors.forename: Andrew
authors.initials: A
authors.lastname: Muir
authors.forename: John G
authors.initials: JG
authors.lastname: McHutchison
mesh_terms: D000743:Anemia, Hemolytic / Q000139:chemically induced* / Q000188:drug therapy*; D004921:Erythropoietin / Q000627:therapeutic use*; D005260:Female; D019698:Hepatitis C, Chronic / Q000175:diagnosis / Q000188:drug therapy; D006801:Humans; D008297:Male; D011379:Prognosis; D012254:Ribavirin / Q000009:adverse effects* / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D004921:Erythropoietin; D012254:Ribavirin